2PCP

ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE


Sequence Similarity Clusters for the Entities in PDB 2PCP

Entity #1 | Chains: A,C
IMMUNOGLOBULIN protein, length: 216 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 53818
95 % 74 170 206
90 % 79 180 181
70 % 813 2557 2
50 % 2121 6625 1
40 % 2122 6626 1
30 % 2137 6673 1
Entity #2 | Chains: B,D
IMMUNOGLOBULIN protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 53819
95 % 1 1 36377
90 % 1 1 34796
70 % 1015 3169 1
50 % 2122 6625 1
40 % 2123 6626 1
30 % 2138 6673 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 6UCF 1 L N123-VRC34_pI4 light chain 9606
17 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
18 5YD4 1 A, C, E, G scFv 4B08 10090
19 5YD3 1 A, C, E, G scFv 4B08 10090
20 6OC7 1 H Heavy chain of HMP42 Fab 9606
21 6OC7 2 L Light chain for HMP42 Fab 9606
22 5UD9 1 H Fab heavy chain 9606
23 5UD9 2 L Light chain 9606
24 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
25 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
26 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
27 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
28 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
29 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
30 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
31 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
32 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
33 6MEE 2 B, D antibody HEPC74 Light Chain 9606
34 6BJZ 1 H 5c8 Fab Heavy chain 9606
35 6BJZ 2 L 5c8 Fab Light chain 9606
36 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
37 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
38 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
39 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
40 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
41 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
42 4XCF 1 L 4E10 Fab light chain 9606
43 4XCF 2 H 4E10 Fab heavy chain 9606
44 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
45 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
46 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
47 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
48 6O24 1 A 4498 Fab heavy chain 9606
49 6O24 2 B 4498 Kappa light chain 9606
50 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
51 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
52 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
53 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
54 6UCE 1 L N123-VRC34_pI3 light chain 9606
55 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
56 5X08 1 H Fab 4E10 Heavy chain 9606
57 5X08 2 L Fab 4E10 Light chain 9606
58 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
59 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
60 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
61 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
62 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
63 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
64 6MEG 1 H antibody HEPC46 Heavy Chain 9606
65 6MEG 2 L antibody HEPC46 Light Chain 9606
66 5C2B 1 H scFv 3B4 9606
67 6O3K 1 L PGZL1.H4K3 light chain 9606
68 6O3K 2 H PGZL1.H4K3 heavy chain 9606
69 4XAW 1 L 4E10 Fab light chain 9606
70 4XAW 2 H 4E10 Fab heavy chain 9606
71 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
72 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
73 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
74 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
75 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
76 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
77 5UCB 1 H Fab Heavy Chain 9606
78 5UCB 2 L Fab Light Chain 9606
79 2VXV 1 H HUMAN IGG ABT-325 9606
80 2VXV 2 L HUMAN IGG ABT-325 9606
81 6QF9 1 A, B scFv 9606
82 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
83 4GXV 1 H, I Antibody 1F1, heavy chain 9606
84 4GXV 2 L, M Antibody 1F1, light chain 9606
85 2VXT 1 H MURINE IGG 125-2H 10090
86 2VXT 3 L MURINE IGG 125-2H 10090
87 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
88 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
89 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
90 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
91 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
92 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
93 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
94 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
95 5W24 1 L 5C4 Fab Light Chain 10090
96 5W24 2 H 5C4 Fab Heavy Chain 10090
97 4HPY 1 H CH59 Fab heavy chain 9606
98 4HPY 2 L CH59 Fab light chain 9606
99 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
100 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
101 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
102 4JG1 1 L Fab light chain 9606
103 4JG1 2 H Fab heavy chain 9606
104 6E65 1 L TB31F Fab light chain 9606
105 6E65 2 H TB31F Fab heavy chain 9606
106 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
107 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
108 5VF2 1 A scFv 2D10 10090
109 5I8C 1 A VRC34.01 Fab heavy chain 9606
110 5I8C 2 B VRC34.01 Fab light chain 9606
111 4O5L 1 L Fab F045-092 light chain 9606
112 4O5L 2 H Fab F045-092 heavy chain 9606
113 5MYX 1 A, C Fab c#24 light chain 10090
114 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
115 3IFL 1 L 12A11 FAB antibody light chain 10090
116 3IFL 2 H 12A11 FAB antibody heavy chain 10090
117 5WK2 1 L M116 LIGHT CHAIN 9606
118 5WK2 2 H M116 HEAVY CHAIN FD 9606
119 3PP4 1 H GA101 Fab heavy chain 10090
120 3PP4 2 L GA101 Fab light chain 10090
121 3KDM 1 A, L Immunoglobulin light chain 9606
122 3KDM 2 B, H Immunoglobulin heavy chain 9606
123 5NIV 1 A Light chain of 5D3 Fab 10090
124 5NIV 2 B Heavy chain of 5D3 Fab 10090
125 6UG7 1 L ch28/11 Fab light chain 10090
126 6UG7 2 H ch28/11 Fab heavy chain 10090
127 5N4J 1 L LIGHT CHAIN 9606
128 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
129 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
130 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
131 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
132 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
133 5X4G 1 A 6H8 Fab heavy chain 10090
134 5X4G 2 B 6H8 Fab light chain 10090
135 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
136 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
137 4PTU 1 A Antibody pn132p2C05, light chain 9606
138 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
139 4TPR 1 L If kappa light chain 10090
140 4TPR 2 H Fab heavy chain 10090
141 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
142 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
143 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
144 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
145 3IFN 1 H 12A11 FAB antibody heavy chain 10090
146 3IFN 2 L 12A11 FAB antibody light chain 10090
147 5U3P 1 H DH511.4 Fab Heavy Chain 9606
148 5U3P 2 L DH511.4 Fab Light Chain 9606
149 6BLA 1 H AMM01 Fab Heavy chain 9606
150 6BLA 2 L AMM01 Fab Light chain 9606
151 4TOY 1 H 35O22 Fab Heavy chain 9606
152 4TOY 2 L 35O22 Fab Light chain 9606
153 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
154 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
155 3NPS 2 B S4 FAB HEAVY CHAIN 9606
156 3NPS 3 C S4 FAB LIGHT CHAIN 9606
157 5I4F 1 A scFv 2D10 10090
158 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
159 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
160 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
161 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
162 5WN9 1 H scFv 2D10 9606
163 4XC3 1 L 4E10 Fab light chain 9606
164 4XC3 2 H 4E10 Fab heavy chain 9606
165 4M5Y 1 H, I Fab 5J8 heavy chain 9606
166 4M5Y 2 L, M Fab 5J8 light chain 9606
167 4TQE 1 L If kappa light chain 10090
168 4TQE 2 H Fab heavy chain 10090
169 5YY4 1 A scFv 4B08 10090
170 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
171 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
172 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
173 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
174 6Q19 1 L Fab lambda chain 9606
175 6Q19 2 H Fab heavy chain 9606
176 6PDR 1 L antibody vFP25.18 light chain 10090
177 6PDR 2 H antibody vFP25.18 heavy chain 10090
178 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
179 5VSI 2 L CH1/Ckappa Fab light chain 9606
180 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
181 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
182 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
183 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
184 5JXA 1 H VRC03 Heavy chain 9606
185 5JXA 2 L VRC03 Light chain 9606
186 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
187 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
188 6QCU 1 L Light chain 9606
189 6QCU 2 H Heavy chain 9606
190 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
191 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
192 3NTC 1 L Fab light chain 10090
193 3NTC 2 H Fab heavy chain 10090
194 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
195 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
196 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
197 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
198 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
199 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
200 6PBV 1 A, C Fab668 light chain 9606
201 6PBV 2 B, D Fab668 heavy chain 9606
202 6PZG 1 L NA-80 Fab light chain 9606
203 6PZG 2 H NA-80 Fab heavy chain 9606
204 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
205 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
206 6BE3 1 H Fab (F598) Heavy Chain 9606
207 6BE3 2 L Fab (F598) Light Chain 9606
208 4NWU 1 H APE1551 Ab Fab heavy chain 9606
209 4NWU 2 L APE1551 Ab Fab light chain 9606
210 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
211 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
212 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
213 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
214 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
215 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
216 5EWI 1 H VRC38.01 Heavy Chain 9606
217 5EWI 2 L VRC38.01 Light Chain 9606
218 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
219 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
220 5E2W 1 L AT8 LIGHT CHAIN 10090
221 5E2W 2 H AT8 HEAVY CHAIN 10090
222 5MYK 1 A Fab c#17 light chain 10090
223 5MYK 2 B Fab c#17 heavy chain 10090
224 4NZR 1 H PGT135 heavy chain Fab 9606
225 4NZR 2 L PGT135 light chain Fab 9606
226 5MYO 1 A, C Fab c#6 light chain 10090
227 5MYO 2 B, D Fab c#6 heavy chain 10090
228 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
229 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
230 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
231 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
232 5UEL 1 H 354NC102 Fab Heavy Chain 9606
233 5UEL 2 L 354NC102 Fab Light Chain 9606
234 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
235 6WIY 1 H Fab 54-1G05 heavy chain 9606
236 6WIY 2 L Fab 54-1G05 light chain 9606
237 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
238 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
239 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
240 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
241 5E2V 1 L AT8 LIGHT CHAIN 10090
242 5E2V 2 H AT8 HEAVY CHAIN 10090
243 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
244 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
245 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
246 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
247 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
248 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
249 5JUE 1 L light chain of UIC2 Fab 10090
250 5JUE 2 H heavy chain of UIC2 Fab 10090
251 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
252 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
253 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
254 5JR1 1 H 10E8 heavy chain 9606
255 5JR1 2 L 10E8 mature light chain 9606
256 6CA7 1 L PCT64_13C light chain 9606
257 6CA7 2 H PCT64_13C heavy chain 9606
258 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
259 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
260 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
261 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
262 6MVL 2 H Antibody Fab fragment heavy chain 9606
263 6MVL 3 L Antibody Fab fragment light chain 9606
264 5OB5 2 H fAb Heavy chain 9606
265 5OB5 3 L fAb Light chain 9606
266 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
267 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
268 5I66 1 A 8B6 antibody, heavy chain 10090
269 5I66 2 B 8B6 antibody, light chain 10090
270 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
271 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
272 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
273 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
274 6BZY 1 H 22D11 Heavy Chain 10090
275 6BZY 2 L 22D11 Light Chain 10090
276 3QQ9 1 C, L 101F LIGHT CHAIN 10090
277 3QQ9 2 D, H 101F HEAVY CHAIN 10090
278 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
279 5TKK 3 L mouse antibody vFP5.01 light chain 10090
280 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
281 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
282 5W6C 1 H UCA Fab heavy chain 9606
283 5W6C 2 L UCA Fab light chain 9606
284 5I1K 1 L FAB LIGHT CHAIN 9606
285 5I1K 2 H FAB HEAVY CHAIN 9606
286 3OZ9 1 L Fab NC-1 kappa light chain 10090
287 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
288 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
289 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
290 5V7U 1 L CBTAU-22.1 Fab light chain 9606
291 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
292 5UEA 1 A, H Fab Heavy Chain 9606
293 5UEA 3 B, L Fab Light Chain 9606
294 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
295 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
296 6LTG 1 A, C antibody Fab fragment H-chain 10090
297 6LTG 2 B, D antibody Fab fragment L-chain 10090
298 3G5Y 1 A 175 light chain 10090
299 3G5Y 2 B 175 heavy chain 10090
300 5NMV 1 L Fab light chain 10088
301 5NMV 2 H Fab heavy chain 10088
302 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
303 4N8C 2 L, M Light chain of monoclonal antibody 10090
304 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
305 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
306 4HGW 1 A Antibody Fab fragment, light chain 10090
307 4HGW 2 B Antibody Fab fragment, heavy chain 10090
308 1NLB 1 L antibody 19D9D6 light chain 10090
309 1NLB 2 H antibody 19D9D6 heavy chain 10090
310 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
311 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
312 3VFG 1 L 3F8 Light Chain 10090
313 3VFG 2 H 3F8 Heavy Chain 10090
314 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
315 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
316 3QRG 1 L Fab light chain 9606
317 3QRG 2 H Fab heavy chain Fd fragment 9606
318 5M6A 1 A, B, C, D Bence-Jones light chain 9606
319 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
320 4LLY 2 B, D light chain Clambda 9606
321 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
322 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
323 5EZI 1 H Fab c12 heavy chain 9606
324 5EZI 2 L Fab c12 Light chain 9606
325 4K23 1 H anti-uPAR antibody, heavy chain 10090
326 4K23 2 L anti-uPAR antibody, light chain 10090
327 3NCJ 1 L Fab15 Mut8 light chain 9606
328 3NCJ 2 H Fab15 Mut8 heavy chain 9606
329 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
330 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
331 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
332 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
333 5W05 1 L M59 FAB LIGHT CHAIN 10090
334 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
335 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
336 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
337 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
338 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
339 4M61 1 A, C Fab A52 light chain 10090
340 4M61 2 B, D Fab A52 heavy chain 10090
341 5YE3 1 B 2A7D9 VH CH1 chain 10090
342 5YE3 2 A 2A7D9 L chain 10090
343 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
344 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
345 1UM5 1 L Antibody 21H3 L chain 10090
346 1UM5 2 H Antibody 21H3 H chain 10090
347 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
348 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
349 4NWT 1 L APE1531 Ab Fab light chain 9606
350 4NWT 2 H APE1531 Ab Fab heavy chain 9606
351 3WHX 1 A mAb Fab H fragment 10090
352 3WHX 2 B mAb Fab L fragment 10090
353 3NA9 1 L Fab15 light chain 9606
354 3NA9 2 H Fab15 heavy chain 9606
355 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
356 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
357 6RCO 1 A, C R5.004 heavy chain 9606
358 6RCO 2 B, D R5.004 light chain 9606
359 6VBO 1 L DH813 light chain 9606
360 6VBO 2 H DH813 heavy chain 9606
361 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
362 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
363 4LRI 1 A, B MSL-109 Light Chain 9606
364 4LRI 2 C, P MSL-109 Heavy Chain 9606
365 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
366 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
367 4JN2 1 A, L anti dabigatran Fab 10090
368 4JN2 2 B, H anti dabigatran Fab 10090
369 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
370 4XBE 2 H 4E10 Fab heavy chain 9606
371 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
372 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
373 6BE2 1 H Fab (F598) Heavy Chain 9606
374 6BE2 2 L Fab (F598) Light Chain 9606
375 4JFZ 1 L Fab light chain 9606
376 4JFZ 2 H Fab heavy chain 9606
377 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
378 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
379 3WIF 1 A mAb Fab H fragment 10090
380 3WIF 2 B mAb Fab L fragment 10090
381 5U6A 1 A Light Chain 9606
382 5U6A 2 B Heavy Chain 9606
383 6K0Y 1 A Antibody Heavy Chain 9606
384 6K0Y 2 B Antibody Light Chain 9606
385 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
386 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
387 3MBX 1 L X836 LIGHT CHAIN 10090
388 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
389 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
390 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
391 6APC 1 H Epididymis luminal protein 214 9606
392 6APC 2 L IGL@ protein 9606
393 4HHA 1 A Fab KE5 Fab fragment KE5 9606
394 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
395 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
396 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
397 4RGO 2 H 14G8 heavy chain Fab 10090
398 4RGO 3 L 14G8 light chain Fab 10090
399 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
400 5GRY 1 A, G diabody 9606
401 5UEK 2 H Fab 12E Heavy Chain 9606
402 5UEK 3 L Fab 12E Light Chain 9606
403 3NAA 1 L Fab15 Mut5 light chain 9606
404 3NAA 2 H Fab15 Mut5 heavy chain 9606
405 1Q0X 1 L Fab 9B1, light chain 10090
406 1Q0X 2 H Fab 9B1, heavy chain 10090
407 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
408 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
409 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
410 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
411 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
412 5IK3 2 B, D 1E03 Fab fragment light chain 9606
413 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
414 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
415 5XLI 1 a, b FabL 10090
416 5XLI 2 c, d FabH 10090
417 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
418 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
419 6DC4 1 H Fab AM22 Heavy Chain 9606
420 6DC4 2 L Fab AM22 Light Chain 9606
421 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
422 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
423 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
424 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
425 4WUK 1 H CH65 heavy chain 9606
426 4WUK 2 L CH65 light chain 9606
427 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
428 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
429 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
430 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
431 5JOP 1 D, L Fab 14.22 light chain 10090
432 5JOP 2 E, H Fab14.22 heavy chain 10090
433 4HPO 1 H CH58 Fab heavy chain 9606
434 4HPO 2 L CH58 Fab light chain 9606
435 6VLN 1 H 4498 Fab heavy chain 9606
436 6VLN 2 L 4498 Fab light chain 9606
437 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
438 5UKN 2 L DH522UCA Fab fragment light chain 9544
439 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
440 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
441 5IT2 1 H heavy chain 9606
442 5IT2 2 L light chain 9606
443 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
444 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
445 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
446 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
447 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
448 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
449 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
450 5MO3 3 L Fab of monoclonal antibody, light chain 10090
451 6L8T 1 B, D, L Antibody light chain 9606
452 6L8T 2 A, C, H Antibody heavy chain 9606
453 5GZ0 1 A, C FM329 light chain 1383439
454 5GZ0 2 B, D FM329 heavy chain 1383439
455 6DW2 1 A 6078 Fab light chain 9606
456 6DW2 2 B 6078 Fab heavy chain 9606
457 6SS0 1 HHH, III Fab C0021181 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
458 6SS0 2 LLL, MMM Fab C0021181 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
459 6MG4 1 A, B JTO light chain 9606
460 6BQB 1 L MGG4 Fab light chain 9606
461 6BQB 2 H MGG4 Fab heavy chain 9606
462 4PUB 1 H DX-2930 HEAVY CHAIN 9606
463 4PUB 2 L DX-2930 LIGHT CHAIN 9606
464 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
465 6B14 2 L Light chain of Fab BL3-6S97N 10090
466 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
467 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
468 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
469 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
470 5GS3 1 A, H diabody protein 9606
471 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
472 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
473 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
474 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
475 5VKD 2 H Fab Heavy Chain 9606
476 5VKD 3 L Fab light chain 9606
477 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
478 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
479 5XHG 1 A, C polypeptide(L) 10090
480 5XHG 2 B, D polypeptide(H) 10090
481 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
482 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
483 3UYR 1 H antibody Fab heavy chain 10090
484 3UYR 2 L antibody Fab light chain 10090
485 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
486 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
487 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
488 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
489 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
490 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
491 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
492 3OAZ 2 K, L Fab 2G12, light chain 9606
493 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
494 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
495 1ZAN 1 L Fab AD11 Light Chain 10116
496 1ZAN 2 H Fab AD11 Heavy Chain 10116
497 6CJK 1 A, C Immunoglobulin Fab light chain 9986
498 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
499 4N0Y 1 H IGH526 Heavy Chain 9606
500 4N0Y 2 L IGH526 Light Chain 9606
501 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
502 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
503 6OTC 2 H sFab H3 heavy chain 32630
504 6OTC 3 L sFab H3 light chain 32630
505 6Q1G 1 L H1244 Fab lambda chain 9606
506 6Q1G 2 H H1244 Fab heavy chain 9606
507 5MTH 1 A, H antibody Fab heavy chain 10090
508 5MTH 2 B, L antibody Fab light chain 10090
509 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
510 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
511 6O26 1 A 3246 Fab heavy chain 9606
512 6O26 2 B 3246 Fab light chain 9606
513 1RZF 1 L Fab E51 light chain 9606
514 1RZF 2 H Fab E51 heavy chain 9606
515 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
516 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
517 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
518 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
519 6WJ0 1 H Fab 54-4H03 heavy chain 9606
520 6WJ0 2 L Fab 54-4H03 light chain 9606
521 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
522 4KTE 2 L GE148 Light Chain Fab 9544
523 5I8O 1 H HMM5 antibody heavy chain 9606
524 5I8O 2 L HMM5 antibody light chain 9606
525 4JG0 1 L Fab light chain 9606
526 4JG0 2 H Fab heavy chain 9606
527 6LKT 1 A antibody Fab fragment H chain 10090
528 6LKT 2 B antibody Fab Fragment L-chain 10090
529 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
530 4YGV 2 B, L aDabi-Fab2a light chain 9606
531 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
532 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
533 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
534 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
535 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
536 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
537 3EO0 1 A, C GC-1008 Fab Light Chain 10090
538 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
539 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
540 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
541 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
542 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
543 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
544 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
545 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
546 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
547 4FQI 3 H antibody CR9114 heavy chain Fab 9606
548 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
549 6S5A 2 H anti P329G LALA Fab heavy chain 10090
550 6S5A 3 L anti P329G LALA Fab light chain 10090
551 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
552 4JHA 2 L D25 light chain 9606
553 6SS5 1 HHH Fab C0020187 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
554 6SS5 2 LLL Fab C0020187 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
555 6B9Z 1 A Trastuzumab Fab light chain 10090
556 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
557 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
558 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
559 4PTT 1 A Antibody pn132p2C05, light chain 9606
560 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
561 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
562 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
563 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
564 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
565 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
566 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
567 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
568 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
569 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
570 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
571 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
572 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
573 4DGV 1 H HCV1 Heavy Chain Fab 9606
574 4DGV 2 L HCV1 Light Chain 9606
575 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
576 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
577 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
578 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
579 5TH2 1 A, C cetuximab Fab, light chain 10090
580 5TH2 2 B, D cetuximab Fab, heavy chain 10090
581 5I8K 1 L HHH1 Fab Light chain 9606
582 5I8K 2 H HHH1 Fab Heavy chain 9606
583 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
584 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
585 6ULF 1 A 4498 Fab heavy chain 9606
586 6ULF 2 B 4498 Fab light chain 9606
587 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
588 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
589 1YNL 1 L Ig gamma light chain 10090
590 1YNL 2 H Ig gamma heavy chain 10090
591 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
592 5EPM 2 B, F Antibody Fab fragment light chain 10090
593 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
594 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
595 3UMT 1 A scFv heavy chain and light chain 10090
596 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
597 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
598 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
599 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
600 6UC5 1 H Fab397 heavy chain 9606
601 6UC5 2 L Fab397 light chain 9606
602 6PEC 1 L antibody light chain 9544
603 6PEC 2 H antibody heavy chain 9544
604 4NUJ 1 A PGT152 light chain 9606
605 4NUJ 2 B PGT152 heavy chain 9606
606 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
607 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
608 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
609 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
610 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
611 3U2S 2 B, L PG9 light chain 9606
612 6PE7 1 H FAB Heavy Chain 9606
613 6PE7 2 L FAB Light chain 9606
614 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
615 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
616 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
617 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
618 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
619 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
620 4NUG 1 L PGT151 light chain 9606
621 4NUG 2 H PGT151 heavy chain 9606
622 7BZ5 2 H Heavy chain of B38 9606
623 7BZ5 3 L Light chain of B38 9606
624 3IU4 1 H chP3 Fab heavy chain 10090
625 3IU4 2 L chP3 Fab light chain 10090
626 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
627 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
628 6DC8 1 L IgG light chain 10090
629 6DC8 2 H IgG heavy chain 10090
630 6NYQ 1 L 1H3 Fab light chain 10090
631 6NYQ 2 H 1H3 Fab heavy chain 10090
632 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
633 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
634 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
635 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
636 6IAS 1 H Fab NKp46-1 heavy chain 32630
637 6IAS 2 L Fab NKp46-1 light chain 32630
638 1P7K 1 A, L antibody light chain FAB 10090
639 1P7K 2 B, H antibody heavy chain FAB 10090
640 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
641 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
642 3RVV 2 C 4C1 - light chain 10090
643 3RVV 3 D 4C1 - heavy chain 10090
644 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
645 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
646 3P0Y 2 H Fab DL11 heavy chain 9606
647 3P0Y 3 L Fab DL11 light chain 9606
648 4NPY 1 A, L germline PGT121 light chain Fab 9606
649 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
650 6ANA 2 H LL2 Fab Heavy Chain 10090
651 6ANA 3 L LL2 Fab Light Chain 10090
652 5IBU 1 B, L 6652 Light Chain 9606
653 5IBU 2 G, H 6652 Heavy Chain 9606
654 5VPL 2 C 4C1 - LIGHT CHAIN 10090
655 5VPL 3 D 4C1 - HEAVY CHAIN 10090
656 6AOD 1 A FXIa Antibody FAB Light Chain 9606
657 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
658 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
659 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
660 2YPV 2 H FAB 12C1 10090
661 2YPV 3 L FAB 12C1 10090
662 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
663 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
664 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
665 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
666 4JY5 1 L PGT122 light chain Fab 9606
667 4JY5 2 H PGT122 heavy chain Fab 9606
668 6ELE 1 A, H fAB heavy chain 9606
669 6ELE 2 B, L fAB light chain 9606
670 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
671 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
672 6B5R 1 H CIS42 Fab Heavy chain 9606
673 6B5R 2 L CIS42 Fab Light chain 9606
674 3NAC 1 L Fab15 Mut7 light chain 9606
675 3NAC 2 H Fab15 Mut7 heavy chain 9606
676 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
677 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
678 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
679 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
680 1Q72 1 L Fab M82G2, Light chain 10090
681 1Q72 2 H Fab M82G2, Heavy chain 10090
682 6XCA 1 H C105 Heavy Chain 9606
683 6XCA 2 L C105 Light Chain 9606
684 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
685 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
686 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
687 6MNQ 3 L Ab DH727.2 light chain 9544
688 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
689 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
690 4YHO 1 H aDabi-Fab3 heavy chain 9606
691 4YHO 2 L aDabi-Fab3 light chain 9606
692 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
693 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
694 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
695 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
696 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
697 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
698 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
699 4DGY 1 H HCV1 Heavy Chain Fab 9606
700 4DGY 2 L HCV1 Light Chain 9606
701 5EN2 1 A GD01 heavy chain 10090
702 5EN2 2 B GD01 light chain 10090
703 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
704 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
705 6P4Y 1 H 4A10 Fab heavy chain 10090
706 6P4Y 2 L 4A10 Fab light chain 10090
707 3MXW 2 L 5E1 light chain 9606
708 3MXW 3 H 5E1 heavy chain 9606
709 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
710 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
711 3EO9 1 L Efalizumab Fab fragment, light chain 9606
712 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
713 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
714 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
715 6N35 1 K, L Fab 2G12 light chain 9606
716 6N35 2 H, M Fab 2G12 heavy chain 9606
717 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
718 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
719 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
720 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
721 5WUV 1 L light chain 9606
722 5WUV 2 H heavy chain 9606
723 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
724 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
725 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
726 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
727 4JM4 1 H PGT 135 Heavy Chain Fab 9606
728 4JM4 2 L PGT 135 Light Chain Fab 9606
729 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
730 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
731 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
732 5YE4 2 B, D 1A9D7 L chain 10090
733 6B0G 1 C 1245 Antibody, Light Chain 9606
734 6B0G 2 D 1245 Antibody, Heavy Chain 9606
735 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
736 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
737 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
738 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
739 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
740 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
741 6D0X 1 A 2140 Antibody, heavy chain 9606
742 6D0X 2 B 1210 Antibody, light chain 9606
743 6BE4 1 H Fab (F598) Heavy Chain 9606
744 6BE4 2 L Fab(F598) Light Chain 9606
745 5TPP 1 L DH270.5 Fab heavy chain 9606
746 5TPP 2 H DH270.5 Fab light chain 9606
747 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
748 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
749 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
750 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
751 6P7H 1 B Antibody DF2F-b.04 light chain 9479
752 6P7H 2 A Antibody DF2F-b.04 heavy chain 9479
753 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
754 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
755 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
756 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
757 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
758 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
759 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
760 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
761 5TL5 1 L M2177 LIGHT CHAIN 10090
762 5TL5 2 H M2177 HEAVY CHAIN 10090
763 2FX7 1 L Fab 4E10 Light Chain 9606
764 2FX7 2 H Fab 4E10 Heavy Chain 9606
765 6O39 1 A Antibody F2.I Fab, Light chain 9606
766 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
767 5Y9K 1 L belimumab light chain 9606
768 5Y9K 2 H belimumab heavy chain 9606
769 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
770 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
771 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
772 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
773 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
774 6GLW 3 D, L Fab 1D11 - Light chain 9844
775 3WFH 1 A mAb Fab H fragment 10090
776 3WFH 2 B mAb Fab L fragment 10090
777 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
778 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
779 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
780 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
781 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
782 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
783 6GKU 2 H Fab 6F5 - Heavy Chain 9844
784 6GKU 3 L Fab 6F5 - Light chain 9844
785 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
786 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
787 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
788 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
789 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
790 5HI4 3 D, L CAT-2000 FAB light chain 9606
791 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
792 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
793 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
794 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
795 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
796 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
797 3RVW 2 C 4C1 - light chain 10090
798 3RVW 3 D 4C1 - heavy chain 10090
799 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
800 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
801 5XKU 2 B HNIgGA6 light chain 9606
802 5XKU 3 C HNIgGA6 heavy chain 9606
803 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
804 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
805 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
806 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
807 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
808 5HI5 3 D, L CAT-2000 light chain 9606
809 5JO5 1 A, C, E, H 10E8 gHV 9606
810 5JO5 2 B, D, F, L 10E8 gLV 9606
811 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
812 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
813 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
814 5CCK 2 L Antibody 3BC315 Fab light chain 9606
815 6GXX 1 H FAB 1D9 heavy chain 10090
816 6GXX 2 L FAB 1D9 light chain 10090
817 6JP7 1 H immunoglobulin Fab heavy chain 9606
818 6JP7 2 L immunoglobulin Fab light chain 9606
819 5I76 1 A, C FM318_light_chain 1383439
820 5I76 2 B, D FM318_heavy_cahin 1383439
821 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
822 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
823 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
824 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
825 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
826 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
827 5I18 1 L FAB LIGHT CHAIN 9606
828 5I18 2 H FAB HEAVY CHAIN 9606
829 6QB3 2 X scFv55 9606
830 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
831 4JN1 2 L anti-dabigatran Fab1, light chain 10090
832 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
833 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
834 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
835 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
836 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
837 4G5Z 2 L canakinumab antibody fragment light chain 9606
838 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
839 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
840 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
841 6SF6 1 A, H COMP-reactive monoclonal antibody 15A Fab fragment, heavy chain 10090
842 6SF6 2 B, L COMP-reactive monoclonal antibody 15A Fab fragment, light chain 10090
843 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
844 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
845 2OK0 2 L Fab ED10 light chain 10090
846 2OK0 3 H Fab ED10 heavy chain 10090
847 6P4C 1 L HyHEL10 Fab light chain 10090
848 6P4C 2 H HyHEL10 Fab heavy chain 10090
849 3SOB 1 L antibody light chain 9606
850 3SOB 3 H antibody heavy chain 9606
851 6UG8 1 L ch28/11 Fab light chain 10090
852 6UG8 2 H ch28/11 Fab heavy chain 10090
853 6B5M 1 H CIS43 Fab Heavy chain 9606
854 6B5M 2 L CIS43 Fab Light chain 9606
855 5AWN 1 H Heavy chain of 3BC176 Fab 9606
856 5AWN 2 L Light chain of 3BC176 Fab 9606
857 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
858 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
859 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
860 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
861 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
862 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
863 5DR5 2 L AbD09097 Fab light chain 9606
864 6MG5 1 A, B Light chain JTO 9606
865 2IH3 1 A FAB Heavy Chain 10090
866 2IH3 2 B FAB Light Chain 10090
867 4KQ3 1 L CNTO3186 light chain Fab 9606
868 4KQ3 2 H CNTO3186 heavy chain Fab 9606
869 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
870 6AQ7 3 L POM6 FAB light CHAIN 10090
871 4JFX 1 A, L Fab light chain 9606
872 4JFX 2 B, H Fab heavy chain 9606
873 3SGE 1 I, L Light Chain 10090
874 3SGE 2 H, J Heavy Chain 10090
875 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
876 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
877 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
878 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
879 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
880 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
881 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
882 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
883 5FHB 1 H Antibody 100 Fab heavy chain 9606
884 5FHB 2 L Antibody 100 Fab light chain 9606
885 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
886 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
887 1JGU 1 L Antibody Light Chain 10090
888 1JGU 2 H Antibody Heavy Chain 10090
889 4I77 1 H Lebrikizumab heavy chain Fab 9606
890 4I77 2 L Lebrikizumab light chain Fab 9606
891 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
892 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
893 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
894 4O4Y 2 H 2095-2 heavy chain 9986
895 5OBF 1 H fAb Heavy chain 10090
896 5OBF 2 L fAb Light chain 10090
897 6QNK 1 A, C FAB light chain 10090
898 6QNK 2 B, D FAB heavy chain 10090
899 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
900 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
901 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
902 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
903 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
904 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
905 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
906 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
907 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
908 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
909 5MHE 1 L Fab-fragment 10090
910 5MHE 2 H Fab-fragment 10090
911 5YFI 1 L Light chain of Fab fragment 10090
912 5YFI 2 H Heavy chain of Fab fragment 10090
913 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
914 4GLR 3 I, K anti-ptau light chain light chain 9031
915 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
916 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
917 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
918 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
919 4HJG 1 A Trastuzumab light chain 9606
920 4HJG 2 B Trastuzumab heavy chain 9606
921 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
922 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
923 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
924 5I30 1 L Fab PL-2 light chain 10090
925 5I30 2 H Fab PL-2 heavy chain 10090
926 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
927 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
928 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
929 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
930 6CT7 1 B, L BIIB054 Fab light chain 9606
931 6CT7 2 A, H BIIB054 Fab heavy chain 9606
932 3FN0 1 L Fab Z13e1 light chain 9606
933 3FN0 2 H Fab Z13e1 heavy chain 9606
934 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
935 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
936 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
937 4YHI 2 B, L aDabi-Fab2a light chain 9606
938 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
939 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
940 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
941 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
942 4OSU 1 H SM5-1 Fab Heavy Chain 9606
943 4OSU 2 L SM5-1 Fab Light Chain 9606
944 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
945 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
946 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
947 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
948 1T2Q 1 L Fab NNA7 Heavy Chain 10090
949 1T2Q 2 H Fab NNA7 Light Chain